Obesity
Not yet recruitingKAI-9531 in Adults With Obesity or Overweight and Diabetes
KAI-9531 in Adults With Obesity or Overweight and Diabetes
Germany- Participants:18–64 years · 65+ years
- Substances:HRS 9531
- Sponsor:Kailera Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany175 clinical trials in Brandenburg An Der Havel, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)KAI-9531 in Adults With Obesity or Overweight and Diabetes
GermanyStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
GermanyStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
GermanyStudy of ABBV-701 and Risankizumab Combination vs Monotherapy in Adults with Moderately to Severely Active Crohn’s Disease or Ulcerative Colitis
GermanyStudy of risankizumab plus anti‑α4β7 integrin antibody versus each alone in adults with moderately to severely active Crohn’s disease or ulcerative colitis
GermanySafety and Efficacy of VX-828, Deutivacaftor, and Tezacaftor in Adults with Cystic Fibrosis
GermanyStudy of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms
GermanyComparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before
GermanyStudy on AP-01 for Patients with Acute Heart Failure (NYHA Class III or Higher)
GermanyStudy to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
GermanyStudy on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne
GermanyStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on inflammatory bowel diseases, including multiple trials investigating novel treatments for ulcerative colitis and Crohn's disease. Studies are evaluating new therapeutic approaches with compounds like eltrekibart, rosnilimab, and obefazimod.
Additional investigations include treatments for gastroparesis and irritable bowel syndrome, exploring both conventional and innovative therapeutic approaches.
Comprehensive research in cancer treatments with a focus on blood cancers and solid tumors. Key studies include evaluation of combination therapies for mantle cell lymphoma and advanced treatment approaches for ovarian cancer.
Trials are investigating innovative drug combinations and immunotherapy approaches to improve patient outcomes.
Important investigations in cardiovascular health and kidney disease, including studies on reducing recurrent cardiovascular events post-heart attack and managing chronic kidney disease with hypertension.
Research focuses on novel therapeutic combinations and preventive strategies for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.